BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23904873)

  • 1. The relationship between Anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome.
    Koutlaki N; Dimitraki M; Zervoudis S; Poiana C; Psillaki A; Nikas I; Liberis A; Badiu C; Liberis V
    J Med Life; 2013 Jun; 6(2):146-50. PubMed ID: 23904873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study.
    Lv PP; Jin M; Rao JP; Chen J; Wang LQ; Huang CC; Yang SQ; Yao QP; Feng L; Shen JM; Feng C
    BMC Endocr Disord; 2020 Jul; 20(1):101. PubMed ID: 32641160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Value of Anti-Müllerian Hormone in Early Post Menarche Adolescent Girls with Polycystic Ovarian Syndrome.
    Kocaay P; Siklar Z; Buyukfirat S; Berberoglu M
    J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):362-366. PubMed ID: 29462707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
    Le MT; Le VNS; Le DD; Nguyen VQH; Chen C; Cao NT
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
    Köninger A; Koch L; Edimiris P; Enekwe A; Nagarajah J; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
    Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China.
    Tian X; Ruan X; Mueck AO; Wang J; Liu S; Yin D; Lu Y; Wu H; Zhang Y
    Gynecol Endocrinol; 2014 Feb; 30(2):126-9. PubMed ID: 24303884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients.
    Köninger A; Koch L; Enekwe A; Birdir C; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Gynecol Endocrinol; 2015 Jan; 31(1):26-30. PubMed ID: 25222840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.